CLINICAL_TRIALS
trial_result
· 2021-08-06
Clinical Trial Update: Effect of AD128 to Treat Obstructive Sleep Apnea [Phase 2, Phase 3]
Summary
A Phase 2/Phase 3 trial update for AD128 in obstructive sleep apnea has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Raphael Heinzer | Conditions: Sleep Apnea, Obstructive | Phase 2, Phase 3 | Status: COMPLETED